Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Asmanex

Generic name: Mometasone furoate

FDA application holder: Organon LLC

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Asmanex?
Asmanex is a brand name of Mometasone furoate, a prescription medicine. The FDA NDC Directory lists 2 Asmanex products in 2 strengths and forms.
Who makes Asmanex?
Organon LLC holds the FDA application for Asmanex (NDA021067, approved March 30, 2005).
Is there a generic or store brand of Asmanex?
Other products of Mometasone furoate are listed with the FDA, but none in exactly the same strength and form as a Asmanex product.
What do pharmacies pay for Asmanex?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 2 Asmanex strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Asmanex been recalled?
FDA enforcement reports list 3 recalls of Asmanex products; the newest started May 28, 2024. A recall usually concerns specific lots, not every product.

What Asmanex is

Each Asmanex product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Mometasone furoate · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
mometasone furoate 110 ug
inhalant (respiratory (inhalation))
Asmanex None listed DailyMed
mometasone furoate 220 ug
inhalant (respiratory (inhalation))
Asmanex None listed DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Mometasone furoate →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Asmanex products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA021067Organon LLCMarch 30, 20052

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Asmanex, by strength and form
Strength and formGeneric or brandPharmacies pay
mometasone furoate 110 ug
inhalant
Brand: Asmanex $88.82 per unit
mometasone furoate 220 ug
inhalant
Brand: Asmanex $36.98–$161.52 per unit
4 packages, lowest to highest

NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Asmanex

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Asmanex products.

Recalls

From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.

  1. May 28, 2024 · Class III · Ongoing · D-0550-2024

    Defective Container

    Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 60 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-02 — Organon Llc

  2. May 28, 2024 · Class III · Ongoing · D-0551-2024

    Defective Container

    Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & Co. Product of Singapore. NDC 78206-114-03 — Organon Llc

  3. January 26, 2022 · Class II · Terminated · D-0169-2024

    CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

    Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Doses, Rx only, Manufactured for: Organon LLC, a subsidiary of Organon & Co., Jersey City, NJ 07302; Manufactured by: MSD Inte — CARDINAL HEALTHCARE

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers